Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Pharmacol Exp Ther. 2003 Oct;307(1):42-52.

Sites of excitatory and inhibitory actions of alcohols on neuronal alpha2beta4 nicotinic acetylcholine receptors.

Author information

  • 1University of Texas at Austin, Waggoner Center for Alcohol and Addiction Research, Austin, TX 78712-0159, USA.

Erratum in

  • J Pharmacol Exp Ther. 2004 Apr;309(1):439.

Abstract

To define potential alcohol binding sites in the neuronal nicotinic acetylcholine receptor (nAChR) we used cysteine mutagenesis and sulfhydryl-specific labeling. The basis of this strategy is that covalent addition of an alkylthiol group to a cysteine in an alcohol binding site will mimic the action of an irreversibly bound alcohol. Each amino acid in the extracellular region of the second transmembrane segment of the nAChR subunit alpha2 was mutated to cysteine. The resulting alpha2 subunits were coexpressed with wild-type beta4in Xenopus laevis oocytes, and the responses were studied using two-electrode voltage clamp. Of the 11 mutants tested, 2 fulfilled criteria for participation in an alcohol binding site: alpha2(L262C)beta4 and alpha2(L263C)beta4. Covalent binding of propanethiol to these cysteines did not change acetylcholine (ACh) affinity, but modified ACh maximal response in both cases: it increased for alpha2(L263C)beta4 and decreased for alpha2(L262C)beta4. The same modifications on ACh responses were obtained with ethanol on alpha2(L263C)beta4 and octanol on alpha2(L262C)beta4. This suggested that alcohol binding at L263 enhances receptor function, whereas binding at L262 inhibits function. We studied different n-alcohols (ethanol, butanol, pentanol, and octanol), as well as isoflurane and urethane, on these two mutants. Covalent binding of propanethiol to the cysteines revealed changes in the alcohol modulation consistent with an excitatory site (L263) or an inhibitory site (L262) being no longer accessible to alcohol. Thus, n-alcohols appear to act on both sites and their ability to enhance (short-chain), inhibit (long-chain), or produce no effect (intermediate-chain) depends upon their relative action at these two sites.

PMID:
14500778
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk